Here is the latest additions to the Mendeley Pancreatic Cancer Genomics papers courtesy of PubMed.
- Combined blockade of integrin {alpha}4{beta}1 plus cytokines SDF-1{alpha} or IL-1{beta} potently inhibits tumor inflammation and growth.
- AGR2 is a Novel Surface Antigen that Promotes the Dissemination of Pancreatic Cancer Cells through Regulation of Cathepsins B and D.
- A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis.
- Silibinin causes apoptosis and cell cycle arrest in some human pancreatic cancer cells.
- Low Expression of TBX4 Predicts Poor Prognosis in Patients with Stage II Pancreatic Ductal Adenocarcinoma.
- Molecular consequences of silencing mutant K-ras in pancreatic cancer cells: justification for K-ras-directed therapy.
- Down-regulation of ZIP4 by RNA interference inhibits pancreatic cancer growth and increases the survival of nude mice with pancreatic cancer xenografts.
- MED29, a component of the mediator complex, possesses both oncogenic and tumor suppressive characteristics in pancreatic cancer.
- Determining the Site of Origin of Mucinous Adenocarcinoma: An Immunohistochemical Study of 175 Cases.
- Somatic Mutations in PIK3CA and Activation of AKT in Intraductal Tubulopapillary Neoplasms of the Pancreas.
- Progress on molecular markers of pancreatic cancer.
- Expression and promoter methylation analysis of ATP-binding cassette genes in pancreatic cancer.
- Significance of combination therapy of zoledronic acid and gemcitabine on pancreatic cancer.
- Pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs.
- Use of a Mouse Model of Pancreatic Neuroendocrine Tumors to Find Pericyte Biomarkers of Resistance to Anti-angiogenic Therapy.
- HuR’s role in gemcitabine efficacy: an exception or opportunity?
- Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway.
- Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) as candidates for tumor markers in patients with pancreatic cancer.